全文获取类型
收费全文 | 97670篇 |
免费 | 7459篇 |
国内免费 | 337篇 |
专业分类
耳鼻咽喉 | 1098篇 |
儿科学 | 2581篇 |
妇产科学 | 1580篇 |
基础医学 | 12939篇 |
口腔科学 | 1276篇 |
临床医学 | 10469篇 |
内科学 | 20336篇 |
皮肤病学 | 1062篇 |
神经病学 | 9682篇 |
特种医学 | 3723篇 |
外国民族医学 | 3篇 |
外科学 | 15975篇 |
综合类 | 1141篇 |
一般理论 | 107篇 |
预防医学 | 7426篇 |
眼科学 | 2375篇 |
药学 | 6877篇 |
中国医学 | 111篇 |
肿瘤学 | 6705篇 |
出版年
2023年 | 676篇 |
2022年 | 461篇 |
2021年 | 2497篇 |
2020年 | 1573篇 |
2019年 | 2541篇 |
2018年 | 2945篇 |
2017年 | 2105篇 |
2016年 | 2222篇 |
2015年 | 2610篇 |
2014年 | 3787篇 |
2013年 | 4929篇 |
2012年 | 7827篇 |
2011年 | 8153篇 |
2010年 | 4493篇 |
2009年 | 3902篇 |
2008年 | 6733篇 |
2007年 | 7109篇 |
2006年 | 6492篇 |
2005年 | 6443篇 |
2004年 | 6010篇 |
2003年 | 5417篇 |
2002年 | 5014篇 |
2001年 | 802篇 |
2000年 | 563篇 |
1999年 | 722篇 |
1998年 | 898篇 |
1997年 | 668篇 |
1996年 | 544篇 |
1995年 | 566篇 |
1994年 | 539篇 |
1993年 | 532篇 |
1992年 | 396篇 |
1991年 | 331篇 |
1990年 | 306篇 |
1989年 | 278篇 |
1988年 | 252篇 |
1987年 | 242篇 |
1986年 | 233篇 |
1985年 | 238篇 |
1984年 | 273篇 |
1983年 | 254篇 |
1982年 | 338篇 |
1981年 | 341篇 |
1980年 | 245篇 |
1979年 | 178篇 |
1978年 | 194篇 |
1977年 | 166篇 |
1976年 | 147篇 |
1975年 | 131篇 |
1974年 | 115篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Triposkiadis Filippos Xanthopoulos Andrew Skoularigis John Starling Randall C. 《Heart failure reviews》2022,27(6):1991-2003
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal... 相似文献
3.
Robinson Sandra M. Scott Jason Ryan Sarah Adams Nicola Hassell Andrew Walker David 《Clinical rheumatology》2022,41(12):3869-3877
Clinical Rheumatology - Educating patients about methotrexate is a core role of rheumatology nurses. We have previously reported the scoring of videoed interviews of rheumatology nurses educating... 相似文献
4.
Olatunde Aishat Hosein Safiyah Paoletti Andrew Pitcairn-Ramirez Alexis Gurney Elizabeth P. 《Maternal and child health journal》2022,26(7):1559-1566
Maternal and Child Health Journal - To compare the prevalence of highly effective contraceptive use by 12 weeks postpartum among participants of Centering Pregnancy®, a model of group... 相似文献
5.
6.
Keith B. Diamond Ivan J. Golub Asad M. Ashraf Samuel J. Swiggett Paul V. Romeo Jack Choueka 《Seminars in Arthroplasty》2022,32(1):15-22
BackgroundWhile studies have demonstrated favorable outcomes in utilization of primary total shoulder arthroplasty (TSA) for the treatment of glenohumeral osteoarthritis (OA), adverse events such as infections can still occur. Periprosthetic joint infections (PJIs) are associated with worse outcomes and patient morbidity. The purpose of this study was to: (1) compare patient demographics amongst TSA patients with and without PJIs following primary TSA; and (2) identify patient-related risk factors for PJIs following primary TSA.MethodsPatients undergoing primary TSA for the treatment of glenohumeral OA were identified using the Mariner administrative claims database by CPT code 23,472. Laterality modifiers were utilized to ensure PJIs were developing in the correct laterality as those patients undergoing primary TSA. Inclusion for the study group consisted of patients who developed PJIs within 2-years after the index procedure, whereas patients who did not develop PJIs served as the comparison cohort. Primary outcomes analyzed included patient demographics and patient-related risk factors for PJIs following primary TSA. A stepwise backwards elimination multivariate binomial logistic regression analyses was performed to determine the odds (OR) of PJIs in patients undergoing primary TSA. A P value less than .05 was considered statistically significant.ResultsThe query yielded 15,396 patients who underwent primary TSA for glenohumeral OA, of which 191 patients developed PJIs and 15,205 did not develop PJIs. The study found statistically significant differences amongst patients who did and did not develop PJIs following primary TSA with respect to age, sex, and presence of comorbid conditions. Risk factors associated with developing PJIs following primary TSA included: pathologic weight loss (OR: 2.06, P < .0001), obesity (OR: 1.56, P = .0001), male sex (OR: 1.52, P = .007), and peripheral vascular disease (OR: 1.46, P = .022).ConclusionAs the number of primary TSAs for the treatment of glenohumeral OA increase worldwide, identifying modifiable risk-factors to reduce the incidence of infection is critical. The study found various modifiable and non-modifiable risk factors associated with developing PJIs following primary TSA. This study is valuable to orthopedists in order to identify and risk-stratify patients with regard to PJI in the setting of primary TSA for OA.Level of EvidenceLevel III; Case-Control Study 相似文献
7.
Naveen Pemmaraju MD Jacqueline S. Garcia MD Andrew Perkins MBBS PhD Jason G. Harb PhD Andrew J. Souers PhD Michael E. Werner PhD Christopher M. Brown PhD Francesco Passamonti MD 《Cancer》2023,129(22):3535-3545
Myelofibrosis is a heterogeneous myeloproliferative neoplasm characterized by chronic inflammation, progressive bone marrow failure, and hepatosplenic extramedullary hematopoiesis. Treatments like Janus kinase inhibitor monotherapy (e.g., ruxolitinib) provide significant spleen and symptom relief but demonstrate limited ability to lead to a durable disease modification. There is an urgent unmet medical need for treatments with a novel mechanism of action that can modify the underlying pathophysiology and affect the disease course of myelofibrosis. This review highlights the role of B-cell lymphoma (BCL) protein BCL-extra large (BCL-XL) in disease pathogenesis and the potential role that navitoclax, a BCL-extra large/BCL-2 inhibitor, may have in myelofibrosis treatment. 相似文献
8.
Cheloff Abraham Z. Song Andrew B. D’Silva Kristin M. Al-Samkari Hanny 《Journal of thrombosis and thrombolysis》2022,53(3):708-711
Journal of Thrombosis and Thrombolysis - Bleeding gastrointestinal angiodysplasia may occur in patients with vasculitis and can be challenging to treat. We describe the novel use of bevacizumab... 相似文献
9.
Keith P. Reber John D. Sivey Matthew Vollmuth Priyansh D. Gujarati 《Journal of labelled compounds & radiopharmaceuticals》2022,65(9):254-263
Parabens are antimicrobial additives found in a wide array of consumer products. However, the halogenated compounds formed from parabens during wastewater disinfection are a potential environmental concern. In order to identify these transformation products and investigate their mechanism of formation, a synthetic route to ethyl parabens labeled with the stable isotope carbon-13 at specific positions within the benzene ring was developed. This efficient two-step procedure starts from commercially available 13C-labeled phenols and involves (1) initial acylation of the phenol via a Houben–Hoesch reaction with trichloroacetonitrile followed by (2) a modified haloform reaction of the resulting trichloromethyl ketone to afford the corresponding 13C-labeled ethyl parabens in 65%–80% overall yield. The scope of the modified haloform reaction was also investigated, allowing for the synthesis of other parabens derived from primary or secondary alcohols, including 13C- and deuterium-labeled esters. In addition, 4-hydroxybenzoic acid can be formed directly from the common trichloromethyl ketone intermediate upon treatment with lithium hydroxide. This protocol complements existing methods for preparing 13C-labeled paraben derivatives and offers the specific advantages of exhibiting complete regioselectivity in the Houben–Hoesch reaction (to form the para-disubstituted product) and avoiding the need for protecting groups in the modified haloform reaction that forms the paraben esters. 相似文献
10.
Della Guardia Lucio Shin Andrew C. 《Journal of molecular medicine (Berlin, Germany)》2022,100(5):677-677
Journal of Molecular Medicine - 相似文献